文献速递眼底病与葡萄膜炎

视盘周围微血管预测糖尿病视网膜病变的发生与发展:一项SS-OCTA研究

Peripapillary Microvasculature Predicts the Incidence and Development of Diabetic Retinopathy: An SS-OCTA Study.
PubMed 文献 · Am J Ophthalmol · 2022-07-16

该前瞻性队列研究纳入1033例2型糖尿病患者的1033只眼,随访2年,用SS-OCTA测量基线视盘周围微血管指标。结果显示较低的视盘周围血管密度和血管长度密度与糖尿病视网膜病变及需转诊糖尿病视网膜病变的发生风险相关,且可提升预测模型的AUC。

要点

  • 较低的全图像和环形视盘周围血管密度及血管长度密度与2年糖尿病视网膜病变发生风险增加相关。
  • 全图像血管密度、环形血管密度和全图像血管长度密度与需转诊糖尿病视网膜病变发生风险相关。
  • 视盘周围血管密度和血管长度密度与糖尿病视网膜病变进展均无显著关联。

核心结论

  • 较低的浅层毛细血管丛视盘周围血管密度和血管长度密度与2型糖尿病人群2年糖尿病视网膜病变及需转诊糖尿病视网膜病变的发生相关。
  • SS-OCTA测量的视盘周围指标可为糖尿病视网膜病变发生与发展的预测提供额外价值。

研究设计与样本

  • 前瞻性队列研究,纳入1033例2型糖尿病患者的1033只眼,随访2年。
  • 基线用扫频源光学相干断层扫描血管成像测量浅层毛细血管丛的视盘周围血管密度和视盘周围血管长度密度。
  • 用7个标准视野立体彩色眼底照相评估糖尿病视网膜病变的发生与进展,采用logistic回归模型校正已确立的危险因素和混杂因素,并用AUROC升高检验OCTA指标的预测价值。

主要发现

  • 无糖尿病视网膜病变眼中2年糖尿病视网膜病变发生率为25.1%(n=222),糖尿病视网膜病变眼中糖尿病视网膜病变进展率为7.4%(n=11),全部眼中需转诊糖尿病视网膜病变发生率为4.17%(n=43)。
  • 校正已确立因素后,较低的全图像视盘周围血管密度(RR=0.81;95%CI=0.68-0.96;P=.015)、环形视盘周围血管密度(RR=0.79;95%CI=0.66-0.95;P=.013)、全图像视盘周围血管长度密度(RR=0.79;95%CI=0.67-0.94;P=.008)和环形视盘周围血管长度密度(RR=0.76;95%CI=0.63-0.91;P=.003)与糖尿病视网膜病变发生风险增加显著相关。
  • 全图像视盘周围血管密度(RR=0.48;95%CI=0.35-0.67;P<.001)、环形视盘周围血管密度(RR=0.65;95%CI=0.45-0.94;P=.023)和全图像视盘周围血管长度密度(RR=0.46;95%CI=0.33-0.66;P<.001)与需转诊糖尿病视网膜病变的发生风险相关。
  • 浅层毛细血管丛的视盘周围血管密度和视盘周围血管长度密度均与糖尿病视网膜病变进展无显著关联。
  • 环形视盘周围血管长度密度使糖尿病视网膜病变发生风险预测模型的AUROC从0.631升至0.658(4.28%;P=.041);全图像视盘周围血管密度、环形视盘周围血管密度和全图像视盘周围血管长度密度均使需转诊糖尿病视网膜病变发生风险预测模型的AUC从0.631升至0.752(19.18%;P=.009)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the associations of peripapillary microvascular metrics with diabetic retinopathy (DR) incidence and development using swept-source optical coherence tomography angiography (SS-OCTA). DESIGN: Prospective cohort study. METHODS: A total of 1033 eyes from 1033 patients with type 2 diabetes mellitus (T2DM) were included, with 2-year follow-up. The peripapillary microvascular metrics at the superficial capillary plexus (SCP) were measured by SS-OCTA at the baseline, including peripapillary vascular density (pVD) and peripapillary vascular length density (pVLD). The DR incidence and progression were evaluated with 7 standard fields of stereoscopic color fundus photographs. The associations were tested with logistic regression models after adjusting for established risk factors and confounding factors. The prediction value of OCTA metrics was examined with the elevation of area under the receiver operating characteristic curve (AUROC). RESULTS: The 2-year incidence of diabetic retinopathy (DR) was 25.1% (n = 222) in non-DR (NDR) eyes, 7.4% DR progression (n = 11) in DR eyes, and 4.17% RDR eyes (n = 43) in all eyes. After adjusting for established factors, lower whole-image pVD (wi-pVD) (relative risk [RR] = 0.81; 95% CI = 0.68-0.96; P = .015), circular pVD (circ-pVD) (RR = 0.79; 95% CI = 0.66-0.95; P = .013), whole-image pVLD (wi-pVLD) (RR = 0.79; 95% CI = 0.67-0.94; P = .008), and circular pVLD (circ-pVLD) (RR = 0.76; 95% CI = 0.63-0.91; P = .003) were significantly associated with increased risk of DR incidence; wi-pVD (RR = 0.48; 95% CI = 0.35-0.67; P < .001), circ-pVD (RR = 0.65; 95% CI = 0.45-0.94; P = .023), and wi-pVLD (RR = 0.46; 95% CI = 0.33-0.66; P < .001) were associated with incident risk of RDR. Both pVD and pVLD of SCP were not significantly associated with DR progression. The AUROC for the DR incidence risk prediction model increased from 0.631 to 0.658 (4.28%; P = .041) by circ-pVLD; the AUC of the RDR incidence risk prediction model increased from 0.631 to 0.752 by wi-pVD (19.18%; P = .009), to 0.752 by circ-pVD (19.18%; P=.009), and to 0.752 by wi-pVLD (19.18%; P = .009). CONCLUSION: Lower pVD and pVLD of SCP are associated with 2-year incident DR and RDR among the T2DM population. The peripapillary metrics imaged by SS-OCTA can provide additional value to the prediction of DR incidence and development.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Yuan M, Wang W, Kang S, et al. Peripapillary Microvasculature Predicts the Incidence and Development of Diabetic Retinopathy: An SS-OCTA Study. Am J Ophthalmol. 2022. PMID: 35850252. doi:10.1016/j.ajo.2022.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。